[Federal Register Volume 81, Number 43 (Friday, March 4, 2016)]
[Notices]
[Pages 11600-11601]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-04864]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION

[Docket No. 50-608; NRC-2013-0053]


SHINE Medical Technologies, Inc.; SHINE Medical Isotope Facility

AGENCY: Nuclear Regulatory Commission.

ACTION: Construction permit and record of decision; issuance.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) is providing 
notice of the issuance of Construction Permit CPMIF-001 to SHINE 
Medical Technologies, Inc. (SHINE) and record of decision, located in 
Janesville, Wisconsin.

ADDRESSES: Please refer to Docket ID NRC-2013-0053 when contacting the 
NRC about the availability of information regarding this document. You 
may obtain publicly-available information related to this document 
using any of the following methods:
     Federal Rulemaking Web site: Go to http://www.regulations.gov and search for Docket ID NRC-2013-0053. Address 
questions about NRC dockets to Carol Gallagher; telephone: 301-415-
3463; email: [email protected]. For technical questions, contact 
the individual listed in the FOR FURTHER INFORMATION CONTACT section of 
this document.
     NRC's Agencywide Documents Access and Management System 
(ADAMS): You may obtain publicly-available documents online in the 
ADAMS Public Documents collection at http://www.nrc.gov/reading-rm/adams.html. To begin the search, select ``ADAMS Public Documents'' and 
then select ``Begin Web-based ADAMS Search.'' For problems with ADAMS, 
please contact the NRC's Public Document Room (PDR) reference staff at 
1-800-397-4209, 301-415-4737, or by email to [email protected]. For 
the convenience of the reader, the ADAMS accession numbers are provided 
in a table in the ``Availability of Documents'' section of this 
document.
     NRC's PDR: You may examine and purchase copies of public 
documents at the NRC's PDR, Room O1-F21, One White Flint North, 11555 
Rockville Pike, Rockville, Maryland 20852.

FOR FURTHER INFORMATION CONTACT: Steven Lynch, Office of Nuclear 
Reactor Regulation, U.S. Nuclear Regulatory Commission, Washington, DC 
20555-0001; telephone: 301-415-1524, email: [email protected]ov.

SUPPLEMENTARY INFORMATION:

I. Introduction

    Under section 2.106 of title 10 of the Code of Federal Regulations 
(10 CFR), the NRC is providing notice of the issuance of Construction 
Permit, CPMIF-001 to SHINE and, issuance of the Record of Decision 
(ROD) under 10 CFR 51.102(c). The construction permit, which is 
immediately effective, authorizes SHINE to construct a facility that 
will house eight utilization facilities and one production facility 
designed for the production of medical radioisotopes, as described in 
SHINE's application for construction permit, in Janesville, Wisconsin. 
With respect to the application for the construction permit filed by 
SHINE, the NRC finds that the applicable standards and requirements of 
the Atomic Energy Act of 1954, as amended (the Act), and the 
Commission's regulations have been met. The NRC finds that any required 
notifications to other agencies or bodies have been duly made and that, 
among other things, there is reasonable assurance that the activities 
authorized by the permit will be conducted in compliance with the rules 
and regulations of the Commission, that safety questions will be 
satisfactorily resolved by the completion of construction, and that, 
taking into consideration siting criteria, the proposed facility can be 
constructed and operated at the proposed location without under risk to 
public health and safety, subject to the conditions listed in the 
construction permit. Furthermore, the NRC finds that the licensee is 
technically and financially qualified to engage in the activities 
authorized, and that issuance of the license will not be

[[Page 11601]]

inimical to the common defense and security or to the health and safety 
of the public. Finally, the NRC finds that the findings required by 
Subpart A of 10 CFR part 51 have been made.
    Accordingly, the immediately effective construction permit was 
issued on February 29, 2016.

II. Further Information

    The NRC prepared a Safety Evaluation Report (SER) and Final 
Environmental Impact Statement (FEIS) that document the information 
reviewed and the NRC's conclusion. The Commission also issued its 
Memorandum and Order documenting its final decision on the mandatory 
hearing held on December 15, 2015, which serves as the ROD in this 
proceeding. The NRC also prepared a document summarizing the ROD to 
accompany its action on the construction permit application that 
incorporates by reference materials contained in the FEIS. In 
accordance with 10 CFR 2.390 of the NRC's ``Agency Rules of Practice 
and Procedure,'' details with respect to this action, including the 
SER, FEIS, summary of the ROD, and accompanying documentation included 
in the construction permit package, as well as the Commission's hearing 
decision and ROD, are available online in the ADAMS Public Documents 
collection at http://www.nrc.gov/reading-rm/adams.html. From this site, 
persons can access the NRC's ADAMS, which provides text and image files 
of NRC's public documents.

III. Availability of Documents

    The documents identified in the following table are available to 
interested persons through one or more of the following methods, as 
indicated.

------------------------------------------------------------------------
                Document                       ADAMS  Accession No.
------------------------------------------------------------------------
Construction Permit No. CPMIF-001.......  ML16041A471
Commission's Memorandum and Order on the  ML16056A094
 mandatory hearing (ROD).
Summary of the Record of Decision.......  ML16041A470
Safety Evaluation Report Related to the   ML15342A396
 SHINE Medical Technologies, Inc.
 Construction Permit Application for a
 Medical Radioisotope Production
 Facility.
NUREG-2183, Final Environmental Impact    ML15288A046
 Statement for the Construction Permit
 for the SHINE Medical Radioisotope
 Production Facility.
SHINE Construction Permit Application...  ML13088A192
                                          ML15259A272
                                          ML15258A431
------------------------------------------------------------------------


    Dated at Rockville, Maryland, this 29 day of February 2016.

    For the Nuclear Regulatory Commission.
Lawrence E. Kokajko,
Director, Division of Policy and Rulemaking, Office of Nuclear Reactor 
Regulation.
[FR Doc. 2016-04864 Filed 3-3-16; 8:45 am]
BILLING CODE 7590-01-P